Current Status of Co-Occurring Mood and Substance Use Disorders: A New Therapeutic Target
Open accessThe DOI matches its Crossref record; 11 of the 11 references it cites were found in a registry or an index.
Abstract
Mood and substance use disorders commonly co-occur, yet there is little evidence-based research to guide the pharmacologic management of these comorbid disorders. The authors review the existing empirical findings, some of which may call into question current clinical pharmacotherapy practices for treating co-occurring mood and substance use disorders. The authors also highlight knowledge gaps that can serve as a basis for future research. The specific mood disorders reviewed are bipolar and major depressive disorders (either one co-occurring with a substance use disorder). Overall, findings from the relatively small amount of available data indicate that pharmacotherapy for managing mood symptoms can be effective in patients with substance dependence, although results have not been consistent across all studies. Also, in most studies, medications for managing mood symptoms did not appear to have an impact on the substance use disorder. In a recent trial for comorbid major depression and alcohol dependence, combination treatment with a medication for depression and another for alcohol dependence was found to reduce depressive symptoms and excessive drinking simultaneously. However, research has only begun to address optimal pharmacologic management of co-occurring disorders. In addition, current clinical treatment for alcohol and drug dependence often excludes new pharmacotherapies approved by the U.S. Food and Drug Administration for treating certain types of addiction. With new data becoming available, it appears that we need to revisit current practice in the pharmacological management of co-occurring mood and substance use disorders.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Kessler, R. C., Chiu, W. T., Demler, O., & Walters, E. E. (2005) · Archives of General Psychiatry · doi:10.1001/archpsyc.62.6.617 · Cited by 12,052
Hasin, D. S., Stinson, F. S., Ogburn, E., & Grant, B. F. (2007) · Archives of General Psychiatry · doi:10.1001/archpsyc.64.7.830 · Cited by 2,908 · cited 1×
“Estimates of the lifetime prevalence of mood and substance use disorders and the comorbidity of these disorders in the general population can be derived from two nationally representative large-scale surveys using DSM-IV diagnostic criteria: the National Epidemiologic Survey on Alcoholism and Related Conditions, which…”
MethodMerikangas, K. R., Akiskal, H. S., Angst, J., Greenberg, P. E., Hirschfeld, R. M. A., Petukhova, M., & Kessler, R. C. (2007) · Archives of General Psychiatry · doi:10.1001/archpsyc.64.5.543 · Cited by 2,399
Kendler, K. S., Prescott, C. A., Myers, J., & Neale, M. C. (2003) · Archives of General Psychiatry · doi:10.1001/archpsyc.60.9.929 · Cited by 1,868 · cited 1×
“Finally, while mood-related symptoms may precede or be precipitated by drug and alcohol dependence, implying causation, there also may be common risk factors for mood and substance use disorders—such as stressful events, psychological trauma, and genetic vulnerability—that lead to co-occurring expression, without one…”
Hasin, D. S., Goodwin, R. D., Stinson, F. S., & Grant, B. F. (2005) · Archives of General Psychiatry · doi:10.1001/archpsyc.62.10.1097 · Cited by 1,645
Conway, K. P., Compton, W., Stinson, F. S., & Grant, B. F. (2006) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v67n0211 · Cited by 934 · cited 1×
“these disorders can be associated with greater severity in the other (18, 20); that alcohol dependence may prolong the course of depression (21); and that depression that persists with abstinence from alcohol can be a risk factor for relapse to drinking (22, 23).”
BackgroundOslin, D. W., Berrettini, W., Kranzler, H. R., Pettinati, H., Gelernter, J., Volpicelli, J. R., & O'Brien, C. P. (2003) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300219 · Cited by 571
Self-citationSalloum, I. M., Cornelius, J. R., Daley, D. C., Kirisci, L., Himmelhoch, J. M., & Thase, M. E. (2005) · Archives of General Psychiatry · doi:10.1001/archpsyc.62.1.37 · Cited by 271
Brown, E. S., Gorman, A. R., & Hynan, L. S. (2007) · Journal of Clinical Psychopharmacology · doi:10.1097/jcp.0b013e31814db4c4 · Cited by 79 · cited 2×
“Only two of the six trials showed a significant reduction in substance use: one using valproate to reduce drinking (29) and the other using citicoline to reduce cocaine use (34).”
BackgroundTolliver, B. K., DeSantis, S. M., Brown, D. G., Prisciandaro, J. J., & Brady, K. T. (2012) · Bipolar Disorders · doi:10.1111/j.1399-5618.2011.00973.x · Cited by 74 · cited 2×
“In some cases, the double-blind medication was also a treatment for bipolar disorder, such as valproate (29) or quetiapine (30, 31); in other cases, it was an FDA-approved medication for treating alcohol dependence, such as naltrexone (32) or acamprosate (33); and in one case it was a nutritional supplement—citicoline…”
BackgroundResult
Cited by
Lai, H. M. X., Cleary, M., Sitharthan, T., & Hunt, G. E. (2015) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2015.05.031 · Cited by 941
Riper, H., Andersson, G., Hunter, S. B., Wit, J., Berking, M., & Cuijpers, P. (2014) · Addiction · doi:10.1111/add.12441 · Cited by 276
Inoculation stress hypothesis of environmental enrichment.
Crofton, E. J., Zhang, Y., & Green, T. A. (2015) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2014.11.017 · Cited by 206
“The rate of comorbidity of major depression with alcohol use disorders is 40.3%, and major depression with a drug use disorder is 17.2% (Pettinati et al., 2013).”
BackgroundInfluentialHan, B., Compton, W. M., Blanco, C., & Colpe, L. J. (2017) · Health Affairs · doi:10.1377/hlthaff.2017.0584 · Cited by 194
Noninvasive brain stimulation treatments for addiction and major depression
Dunlop, K., Hanlon, C. A., & Downar, J. (2017) · Annals of the New York Academy of Sciences · doi:10.1111/nyas.12985 · Cited by 171
Metadata
- Authors
- Pettinati, H. M., O’Brien, C. P., & Dundon, W. D.
- Venue
- American Journal of Psychiatry
- Published
- 2013-01
- Volume
- 170
- Issue
- 1
- Pages
- 23-30
- ISSN
- 0002-953X (ISSN-L)
- 1535-7228
- OpenAlex
- W2156044731
- Cited by
- 252
- References
- 11
- FWCI
- 14.65
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Current Status of Co-Occurring Mood and Substance Use Disorders: A New Therapeutic Target. https://app.cochat.ai/papers/10.1176/appi.ajp.2012.12010112
- The paper
- Pettinati, H. M., O’Brien, C. P., & Dundon, W. D. (2013). Current Status of Co-Occurring Mood and Substance Use Disorders: A New Therapeutic Target. American Journal of Psychiatry. https://doi.org/10.1176/appi.ajp.2012.12010112
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.